# University of Massachusetts Center for Clinical Science and Translational Supplement

> **NIH NIH UL1** · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 2021 · $92,271

## Abstract

PROJECT SUMMARY/ABSTRACT
This proposal is submitted in response to the National Center for Advancing Translational Sciences (NCATS)
Notice of Special Interest (NOSI; NOT-TR-20-014) seeking UL1 Administrative Supplements to add a
dedicated CTSA hub quality assurance/quality control position.

## Key facts

- **NIH application ID:** 10261950
- **Project number:** 3UL1TR001453-05A1S1
- **Recipient organization:** UNIV OF MASSACHUSETTS MED SCH WORCESTER
- **Principal Investigator:** Katherine F. Luzuriaga
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $92,271
- **Award type:** 3
- **Project period:** 2020-12-21 → 2025-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10261950

## Citation

> US National Institutes of Health, RePORTER application 10261950, University of Massachusetts Center for Clinical Science and Translational Supplement (3UL1TR001453-05A1S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10261950. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*